Review article · 2020 · Open access
Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet
Drug Discovery Today, 26(2), 511–524 · Published 17 December 2020 · DOI 10.1016/j.drudis.2020.12.009
In brief
“Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet” is a 2020 review article by Andreas Bender and Isidro Cortés‐Ciriano, published in Drug Discovery Today. OpenAlex counts 493 citations as of 22 November 2026. It is open access under a CC BY licence: the full text is free to read at Drug Discovery Today.
- Citations
- 493
- Most cited in
- 2026 (156)
- Field-weighted impact
- 3.06
- References
- 96
- Authors
- 2
Abstract
Although artificial intelligence (AI) has had a profound impact on areas such as image recognition, comparable advances in drug discovery are rare. This article quantifies the stages of drug discovery in which improvements in the time taken, success rate or affordability will have the most profound overall impact on bringing new drugs to market. Changes in clinical success rates will have the most profound impact on improving success in drug discovery; in other words, the quality of decisions regarding which compound to take forward (and how to conduct clinical trials) are more important than speed or cost. Although current advances in AI focus on how to make a given compound, the question of which compound to make, using clinical efficacy and safety-related end points, has received significantly less attention. As a consequence, current proxy measures and available data cannot fully utilize the potential of AI in drug discovery, in particular when it comes to drug efficacy and safety in vivo. Thus, addressing the questions of which data to generate and which end points to model will be key to improving clinically relevant decision-making in the future.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Bender, A., & Cortés‐Ciriano, I. (2020). Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet. Drug Discovery Today, 26(2), 511–524. https://doi.org/10.1016/j.drudis.2020.12.009
MLA 9
Bender, Andreas, and Isidro Cortés‐Ciriano. “Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet.” Drug Discovery Today, vol. 26, no. 2, 2020, pp. 511–524. https://doi.org/10.1016/j.drudis.2020.12.009.
Chicago
Bender, Andreas and Isidro Cortés‐Ciriano. 2020. “Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet.” Drug Discovery Today 26 (2): 511–524. https://doi.org/10.1016/j.drudis.2020.12.009.
Harvard
Bender, A. and Cortés‐Ciriano, I. (2020) ‘Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet’, Drug Discovery Today, 26(2), pp. 511–524. doi:10.1016/j.drudis.2020.12.009.
IEEE
A. Bender and I. Cortés‐Ciriano, “Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet,” Drug Discovery Today, vol. 26, no. 2, pp. 511–524, 2020, doi: 10.1016/j.drudis.2020.12.009.
BibTeX
@article{bender2020artificial,
title = {{Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet}},
author = {Bender, Andreas and Cortés‐Ciriano, Isidro},
journal = {Drug Discovery Today},
year = {2020},
volume = {26},
number = {2},
pages = {511--524},
doi = {10.1016/j.drudis.2020.12.009},
url = {https://doi.org/10.1016/j.drudis.2020.12.009}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 1 | |
| 2021 | 36 | |
| 2022 | 50 | |
| 2023 | 72 | |
| 2024 | 82 | |
| 2025 | 96 | |
| 2026 | 156 |
Its field-weighted citation impact is 3.06: it has been cited 3.06 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- artificial intelligence
- drug discovery
- clinical success rate
- drug efficacy
- drug safety
- clinical trial design
- target selection
- data generation
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Bender, A., & Cortés‐Ciriano, I. (2020). Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet. Drug Discovery Today, 26(2), 511–524. https://doi.org/10.1016/j.drudis.2020.12.009
How many times has this paper been cited?
493 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Drug Discovery Today: sign in and open the PDF from this page.
Who wrote this paper?
Andreas Bender, Isidro Cortés‐Ciriano.
What is the DOI of this paper?
10.1016/j.drudis.2020.12.009, permanently at https://doi.org/10.1016/j.drudis.2020.12.009. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.